SS Innovations International price to sales ratio SSII

Market value divided by revenue over the last twelve months, since 2024.

Today, Oct 23, 2026: 8.6×
2-year median: 39.5×
Against its 2-year history: 0th; percentile: 0 is its lowest day, 100 its highest
2-year range: 8.6× to 140×
Peer median: 2.0×

SS Innovations International's price to sales ratio is 8.6× as of Oct 23, 2026.

That is below its 2-year median of 39.5×, lower than on 100% of days in the last 2 years.

Over that time it ranged from 8.6× in Oct 2026 to 140× in Mar 2025.

The median for 10 medical instruments and supplies stocks of a similar size is 2.0×.

Price to sales ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	8.6×	8.6×	31.8×
2025	30.8×	29.5×	140×
2024	87.3×	32.0×	87.3×

Against its peers

Companies in Medical - Instruments & Supplies nearest SS Innovations International's size, closest first, today.

Company	Price to sales ratio
SSIISS Innovations International	8.6×
EMBCEmbecta	0.4×
TCMDTactile Systems Technology	1.5×
MDXGMimedx	1.6×
MOVMovado	1.0×
INFUInfuSystem	1.9×
UTMDUtah Medical Products	6.5×
PDEXPro DEX	2.6×
IRMDIradimed	12.7×
STAAStaar Surgical	3.3×
BVSBioventus	2.2×
Peer median	2.0×

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on SS Innovations International

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.